Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline ODD Q4 2025 Earnings EPS Surges Past Estimates as Profitability Improves PVL Q1 2023 Earnings Trust Reports EPS of 013 Amid Energy Royalty Trends Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises APPS Q1 2026 Earnings EPS Surges 845 Above Estimates Shares Rally 57 Adial Pharmaceuticals ADIL Drops 957 as Selling Pressure Mounts Near Key Support MINISO Group MNSO Holds Above Support Despite Slight Dip Key Levels to Watch Prelude Therapeutics PRLD Slides 422 as Stock Approaches Key Support Level DFDVW Dips 491 Warrant Price Tests Key Support Zone WNC Q1 2026 Earnings EPS Falls Short of Expectations Despite Uptick in Shares